ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+5.12%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$77.6M
AUM Growth
+$77.6M
(-60%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-153.06%
Top 10 Holdings %
Top 10 Hldgs %
64.82%
Holding
61
New
11
Increased
2
Reduced
17
Closed
30
Top Buys
| 1 |
Agilent Technologies
A
|
$5.5M |
| 2 |
IQVIA
IQV
|
$4.31M |
| 3 |
Boston Scientific
BSX
|
$3.3M |
| 4 |
Cardinal Health
CAH
|
$3M |
| 5 |
Medtronic
MDT
|
$2.39M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$18.4M |
| 2 |
Becton Dickinson
BDX
|
$16.8M |
| 3 |
Elevance Health
ELV
|
$14.1M |
| 4 |
Sabra Healthcare REIT
SBRA
|
$13.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$6.75M |
Sector Composition
| 1 | Healthcare | 97.47% |
| 2 | Real Estate | 2.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
89bio
ETNB
$1.37B
| $555K | 0.48% |
29,282
+9,697
| +50% | +$184K |
|
27
OrthoPediatrics
KIDS
$524M
| $471K | 0.41% |
+10,741
| New | +$471K |
|
28
Masimo
MASI
$7.43B
| $469K | 0.41% |
+2,850
| New | +$469K |
|
29
Olema Pharmaceuticals
OLMA
$432M
| $363K | 0.32% |
+40,184
| New | +$363K |
|
30
Viking Therapeutics
VKTX
$3.02B
| $336K | 0.29% |
20,754
-36,289
| -64% | -$588K |
|
|
ATNX
31
DELISTED
Athenex, Inc. Common Stock
ATNX
| – | – |
-42,651
| Closed | -$56.7K |
|
|
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-64,704
| Closed | -$1.57M |
|
|
GRTS
33
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-540,657
| Closed | -$1.5M |
|
|
CTLT
34
DELISTED
CATALENT, INC.
CTLT
| – | – |
-9,144
| Closed | -$601K |
|
35
Zimmer Biomet
ZBH
$20.8B
| – | – |
-9,283
| Closed | -$1.2M |
|
36
Dentsply Sirona
XRAY
$2.77B
| – | – |
-55,992
| Closed | -$2.2M |
|
37
Thermo Fisher Scientific
TMO
$183B
| – | – |
-3,744
| Closed | -$2.16M |
|
|
38
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-762,264
| Closed | -$6.75M |
|
39
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
|
40
Sabra Healthcare REIT
SBRA
$4.56B
| – | – |
-1,165,923
| Closed | -$13.4M |
|
41
ResMed
RMD
$39.4B
| – | – |
-6,345
| Closed | -$1.39M |
|
42
uniQure
QURE
$954M
| – | – |
-71,040
| Closed | -$1.43M |
|
43
PTC Therapeutics
PTCT
$4.41B
| – | – |
-53,247
| Closed | -$2.58M |
|
44
Pfizer
PFE
$141B
| – | – |
-73,265
| Closed | -$2.99M |
|
45
Maravai LifeSciences
MRVI
$341M
| – | – |
-20,753
| Closed | -$291K |
|
46
Moderna
MRNA
$9.36B
| – | – |
-36,130
| Closed | -$5.55M |
|
47
McKesson
MCK
$85.9B
| – | – |
-7,312
| Closed | -$2.6M |
|
48
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-80,455
| Closed | -$492K |
|
49
Icon
ICLR
$14B
| – | – |
-26,830
| Closed | -$5.73M |
|
50
DexCom
DXCM
$30.9B
| – | – |
-22,185
| Closed | -$2.58M |
|